XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets, Current [Abstract]    
Cash and cash equivalents $ 20,610 $ 21,903
Accounts receivable, net of allowances of $1,626 and $1,241 at March 31, 2024 and December 31, 2023 71,862 65,545
Inventories 72,718 71,563
Income tax receivable 11,952 11,885
Prepaid Expense and Other Assets 5,957 2,464
Other current assets 10,439 9,194
Total current assets 193,538 182,554
Property, plant and equipment, net of accumulated depreciation of $260,340 and $254,013 at March 31, 2024 and December 31, 2023 179,647 185,812
Operating lease right-of-use assets 42,141 43,357
Intangible assets, net 55,268 58,724
Investment in joint venture 34,409 32,701
Deferred tax assets 734 734
Other non-current assets 7,087 7,003
Total assets 512,824 510,885
Liabilities, Current [Abstract]    
Accounts payable 50,786 45,480
Accrued salaries, wages and benefits 16,920 15,464
Income tax payable 431 524
Short-term debt and current maturities of long-term debt 7,014 3,910
Current portion of operating lease liabilities 5,177 5,735
Other current liabilities 14,464 10,506
Total current liabilities 94,792 81,619
Deferred tax liabilities 4,739 4,988
Long-term debt, net of current maturities 151,531 149,369
Operating lease liabilities, net of current portion 45,803 47,281
Other non-current liabilities 18,349 24,827
Total liabilities 315,214 308,084
Commitments and contingencies (Note 10)
Common stock - $0.01 par value per share, 90,000 shares authorized, 49,520 and 47,269 shares issued and outstanding at March 31, 2024 and December 31, 2023 495 473
Additional paid-in capital 464,081 457,632
Accumulated deficit (307,885) (295,348)
Accumulated other comprehensive loss (40,550) (37,755)
Total stockholders’ equity 116,141 125,002
Total liabilities, preferred stock, and stockholders’ equity 512,824 510,885
Series D Preferred Stock    
Liabilities, Current [Abstract]    
Series D perpetual preferred stock - $0.01 par value per share, 65 shares authorized, issued and outstanding at March 31, 2024 and December 31, 2023 $ 81,469 $ 77,799